PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Actinium Pharmaceuticals, Inc. (ATNM)
1.780.01 (-0.56%)
1.75 - 1.81
1.03 - 2.41
122.5K / 296.7K (Avg.)
-1.36 | -1.31
Gauges a company's environmental, social, and governance practices.
60.35
ESG score 90-95% of MDGL's 64.08. Bill Ackman would demand clear ESG improvement catalysts.
57.07
Environmental score 80-90% of MDGL's 64.58. Walter Schloss would scrutinize carbon exposure and transition planning.
60.74
Social score 90-95% of MDGL's 64.61. Bill Ackman would demand clear social improvement catalysts.
63.25
Similar governance score to MDGL's 63.04. Bruce Berkowitz would investigate if industry governance norms adequately protect shareholder value.